154 related articles for article (PubMed ID: 12373538)
1. The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: review article.
Gołembiowska K; Konieczny J; Ossowska K; Wolfarth S
Amino Acids; 2002; 23(1-3):199-205. PubMed ID: 12373538
[TBL] [Abstract][Full Text] [Related]
2. The role of striatal metabotropic glutamate receptors in Parkinson's disease.
Ossowska K; Konieczny J; Wardas J; Gołembiowska K; Wolfarth S; Pilc A
Amino Acids; 2002; 23(1-3):193-8. PubMed ID: 12373537
[TBL] [Abstract][Full Text] [Related]
3. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
[TBL] [Abstract][Full Text] [Related]
5. Regulation of striatal dopamine release by metabotropic glutamate receptors.
Verma A; Moghaddam B
Synapse; 1998 Mar; 28(3):220-6. PubMed ID: 9488507
[TBL] [Abstract][Full Text] [Related]
6. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.
Bonsi P; Cuomo D; Picconi B; Sciamanna G; Tscherter A; Tolu M; Bernardi G; Calabresi P; Pisani A
Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415
[TBL] [Abstract][Full Text] [Related]
7. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
[TBL] [Abstract][Full Text] [Related]
8. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
[TBL] [Abstract][Full Text] [Related]
9. An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
Ossowska K; Konieczny J; Wardas J; Pietraszek M; Kuter K; Wolfarth S; Pilc A
Amino Acids; 2007 Feb; 32(2):179-88. PubMed ID: 16699817
[TBL] [Abstract][Full Text] [Related]
10. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats.
Gołembiowska K; Konieczny J; Wolfarth S; Ossowska K
Neuropharmacology; 2003 Sep; 45(4):484-92. PubMed ID: 12907309
[TBL] [Abstract][Full Text] [Related]
12. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
Oueslati A; Breysse N; Amalric M; Kerkerian-Le Goff L; Salin P
Eur J Neurosci; 2005 Dec; 22(11):2765-74. PubMed ID: 16324110
[TBL] [Abstract][Full Text] [Related]
13. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
14. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
15. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
Lavoute C; Weiss M; Rostain JC
Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
[TBL] [Abstract][Full Text] [Related]
16. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease.
Morales I; Sabate M; Rodriguez M
Eur J Neurosci; 2013 Jul; 38(1):2172-82. PubMed ID: 23565852
[TBL] [Abstract][Full Text] [Related]
17. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
18. Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction.
Matarredona ER; Santiago M; Venero JL; Cano J; Machado A
J Neurochem; 2001 Jan; 76(2):351-60. PubMed ID: 11208898
[TBL] [Abstract][Full Text] [Related]
19. Striatal ablation of GABAergic neurons prevents the in vivo neuroprotective effect of DCG-IV against the MPP+-induced neurotoxicity on dopaminergic nerve terminals.
Venero JL; Mauriño R; Machado A; Santiago M
Neurochem Int; 2010 Dec; 57(8):979-84. PubMed ID: 20974202
[TBL] [Abstract][Full Text] [Related]
20. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
